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BAG1 prevents misfolded proteins accumulation when
autophagy ﬂux is blocked in neurodegenerative
disorders
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Different disease associated proteins, as SOD1 and TDP-43 in
familial and sporadic amyotrophic lateral sclerosis and frontotem-
poral dementia, or androgen receptor (AR) in spinal and bulbar
muscular atrophy, tend to misfold and accumulate into aggregates in
neurons. Protein quality control system prevents their aggregation
and toxicity by enhancing their degradation via proteasome and/or
autophagy. An efﬁcient dynein mediated transport of misfolded
proteins to the site of degradation is required as key point to control
their aggregation and degradation. HSPB8 is a protective protein
that reduces disease associated proteins aggregation by autophagy
facilitation. Here we evaluated the HSPB8 effects on the recently
discovered RAN translated poly-di-peptides (DPRs) from C9ORF72
gene. Using ﬁlter trap and western blot we observed that HSPB8
over-expression facilitates DPRs clearance even when proteasome is
blocked. when we blocked the dynein retrograde transport by
EHNA we found an alteration of SQSTM1/p62 and LC3 expression
and localization. However, dynein inhibition reduced SQSTM1/p62
and LC3 levels induced by trehalose and drastically reduced the
number of autophagosome per cell. Moreover, EHNA reduced the
PBS insoluble fraction of mutated misfolded proteins and DPRs also
when autophagy is blocked. This effect was counteracted by
proteasome inhibition. Notably, EHNA selectively increased BAG1
mRNA (responsible for misfolded protein degradation via protea-
some) in NSC34 and motoneuron derived from iPS cells, while
exogenous BAG1 overexpression reduced misfolded species aggre-
gation and BAG1 down-regulation blocked the EHNA effect.
Moreover, EHNA increased mRNA and protein levels of chaperone
mediated autophagy receptor Lamp2A, suggesting that CMA can
restore the degradation of misfolded proteins with KFERQ-like
motif that are internalized into lysosome by Lamp2A. Collectively,
these data suggest that when autophagy ﬂux is blocked, misfolded
proteins can be re-routed by BAG1 to alternative degradative
pathways.
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A novel avenue for protection against tauopathy: ADNP/
NAP dramatically increase microtubule end-binding
protein-tau interaction
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Background: Activity-dependent neuroprotective protein
(ADNP), vital for brain formation and cognitive function, is mutated
in autism and linked to neurodegenerative/psychiatric diseases. An
eight-amino-acid peptide snippet of ADNP, NAP (NAPVSIPQ),
identiﬁed as a smallest active fragment, includes the SxIP micro-
tubule (MT) end-binding protein (EB) association motif, and
enhances ADNP-EB3 interaction. Depletion of EB1 or EB3
abolishes NAP protection against zinc intoxication. Furthermore,
NAP enhances Tau-MT interaction, and Tau regulates the localiza-
tion and function of EB1 and EB3 in developing neuronal cells.
Aims: To reveal how NAP (ADNP) enhances Tau-MT interac-
tions and whether this is mediated by EBs.
Methods: NAP impact on the EB’s morphology and dynamics
was estimated by immunoﬂuorescence and time-lapse imaging, EB-
Tau and EB/Tau-MT interactions - by Co-Immunoprecipitation and
Polimeryzed vs. Solible tubulin assay in the differentiated N1E-115
cells.
Results: We showed, for we believe the ﬁrst time, that NAP
augmented endogenous EB1 comet density in the N1E-115
neuroblastoma neuronal model. This ﬁnding was substantiated by
cell transfection with ﬂuorescent EB1 and live cell imaging. NAP
increased comet amounts, length and speed. At the molecular level,
NAP enhanced EB3 homodimer formation, while decreasing EB1-
EB3 heterodimer content and driving EB1- and EB3-Tau interac-
tions (dramatic 20-fold increases), leading to recruitment of EB1/
EB3 and Tau to MTs under zinc intoxication. NAP did not protect
NIH3T3 cells against zinc intoxication, unless these cells were
transfected with Tau.
Conclusions: EB-Tau interaction is identiﬁed as a novel target
for endogenous ADNP neuroprotection, and a future target for drug
development, with NAP as a prototype. (Molecular Psychiatry,
2017; https://doi.org/10.1038/mp.2016.255).
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